A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface
Boehringer Ingelheim
Boehringer Ingelheim
I-Mab Biopharma US Limited
Kansas State University
Hoffmann-La Roche
Revolution Medicines, Inc.
Inova Health Care Services
Cedars-Sinai Medical Center
Medical University of South Carolina
Celldex Therapeutics
Massachusetts General Hospital
Catalysis SL
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
Albert Einstein College of Medicine
Hospices Civils de Lyon
IGF Oncology, LLC
University of Illinois at Chicago
Stanford University
Massachusetts General Hospital
Poniard Pharmaceuticals
Pharmacyclics LLC.